USFDA 483 to Novo Nordisk Cite Lapses in
FDA has published the USFDA Form 483 issued to Novo Nordisk API manufacturing facility at
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
